Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas

被引:109
作者
Bellan, C
Lazzi, S
Hummel, M
Palummo, N
de Santi, M
Amato, T
Nyagol, J
Sabattini, E
Lazure, T
Pileri, SA
Raphael, M
Stein, H
Tosi, P
Leoncini, L
机构
[1] Univ Siena, Dept Human Pathol & Oncol, Nuovo Policlin Scotte, I-53100 Siena, Italy
[2] Inst Pathol, Berlin, Germany
[3] Nairobi Hosp, Dept Human Pathol, Nairobi, Kenya
[4] Policlin S Orsola, LA Seragnoli Haematopathol Unit, I-40138 Bologna, Italy
[5] Univ Paris 11, INSERM, E109, Bicetre Hosp, Paris, France
关键词
D O I
10.1182/blood-2005-01-0168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The normal counterpart of the neoplastic B cells in Burkitt lymphoma (BL) is still unclear. Based on immunoglobulin gene rearrangement studies, some authors suggest an origin from germinal center cells and others from memory B cells. However, most of these studies rely on cell lines or on a small series of cases. To help clarify the cell of origin of BL, seminested polymerase chain reaction (PCR) was performed to amplify the VDJ rearrangements of the immunoglobulin heavy chain (VH) genes, and the resultant amplificates were sequenced for comparison with known germline V-H segments. The results of this approach revealed that all cases (15 endemic BIL [eBL], 10 sporadic BL [sBL], and 6 AIDS-related BL) harbor mutated V-H genes, with different mutation ranges among the 3 types of BL. The eBL and AIDS-related forms showed considerably higher mutation rates than the sBL form (5.1%, 5.4%, and 1.5%, respectively). The mutations in eBL and AIDS-related BL also showed signs of antigen selection, whereas no signs of antigen selection were found in sBL. Finally, after subcloning the amplificates, sequence analysis revealed no signs of ongoing mutations in any of the cases analyzed. Given that one of the main differences between eBL and AIDS-related BL on the one hand and sBL on the other hand is the association with Epstein-Barr virus (EBV), we compared EBV-positive and EBV-negative BLs indepen-dently of their geographic origin and HIV status. The differences in the number of somatic mutations and antigen selection were even more evident when this approach was used. According to our molecular results, it appears that EBV-positive and EBV-negative BL may originate from 2 distinct subsets of B cells, pointing to a particular role for the germinal-center reaction in the pathogenesis of these tumors. The different types of C-MYC translocation reported in BL may also be related to the different stages of B-cell maturation.
引用
收藏
页码:1031 / 1036
页数:6
相关论文
共 58 条
[11]   V-R and V-L gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection [J].
Chapman, CJ ;
Zhou, JX ;
Gregory, C ;
Rickinson, AB ;
Stevenson, FK .
BLOOD, 1996, 88 (09) :3562-3568
[12]   Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes [J].
Cinti, C ;
Leoncini, L ;
Nyongo, A ;
Ferrari, F ;
Lazzi, S ;
Bellan, C ;
Vatti, R ;
Zamparelli, A ;
Cevenini, G ;
Tosi, GM ;
Claudio, PP ;
Maraldi, NM ;
Tosi, P ;
Giordano, A .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :751-760
[13]   TRANSFECTION OF THE C-MYC ONCOGENE INTO NORMAL EPSTEIN-BARR VIRUS-HARBORING B-CELLS RESULTS IN NEW PHENOTYPIC AND FUNCTIONAL FEATURES RESEMBLING THOSE OF BURKITT-LYMPHOMA CELLS AND NORMAL CENTROBLASTS [J].
CUTRONA, G ;
ULIVI, M ;
FAIS, F ;
RONCELLA, S ;
FERRARINI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :699-711
[14]   HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J].
DALLAFAVERA, R ;
BREGNI, M ;
ERIKSON, J ;
PATTERSON, D ;
GALLO, RC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7824-7827
[15]   Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms [J].
De Falco, G ;
Bellan, C ;
Lazzi, S ;
Claudio, P ;
La Sala, D ;
Cinti, C ;
Tosi, P ;
Giordano, A ;
Leoncini, L .
ONCOGENE, 2003, 22 (40) :6214-6219
[16]   Frequent occurrence of deletions and duplications during somatic hypermutation:: Implications for oncogene translocations and heavy chain disease [J].
Goossens, T ;
Klein, U ;
Küppers, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2463-2468
[17]   Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples [J].
Haralambieva, E ;
Banham, AH ;
Bastard, C ;
Delsol, G ;
Gaulard, P ;
Ott, G ;
Pileri, S ;
Fletcher, JA ;
Mason, DY .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) :49-56
[18]   Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo [J].
Hochberg, D ;
Middeldorp, JM ;
Catalina, M ;
Sullivan, JL ;
Luzuriaga, K ;
Thorley-Lawson, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (01) :239-244
[19]   DOWN-REGULATION OF LFA-1 ADHESION RECEPTORS BY C-MYC ONCOGENE IN HUMAN B-LYMPHOBLASTOID CELLS [J].
INGHIRAMI, G ;
GRIGNANI, F ;
STERNAS, L ;
LOMBARDI, L ;
KNOWLES, DM ;
DALLAFAVERA, R .
SCIENCE, 1990, 250 (4981) :682-686
[20]   VH gene analysis in sporadic Burkitt's lymphoma:: Somatic mutation and intraclonal diversity with special reference to the tumor cells involving germinal center [J].
Isobe, K ;
Tamaru, JI ;
Nakamura, S ;
Harigaya, K ;
Mikata, A ;
Ito, H .
LEUKEMIA & LYMPHOMA, 2002, 43 (01) :159-164